Countdown to 2022 CBIIC:

Expert Review Committee

JIANG Hualiang


Academician of Chinese Academy of Sciences
2015-2016 Annual Chairman of PhIRDA
Professor of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

JIANG Jiandong


Academician of Chinese Academy of Engineering
2017-2018 Annual Chairman of PhIRDA
President of Institute of Pharmaceutical Sciences Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College

GU Ning


Academician of Chinese Academy of Sciences
Vice-Chairman of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Chief Professor of Southeast University

LI Jia


Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Director of State Key Laboratory of Drug Research

HU Zhibin


Chairman of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Deputy Secretary of CPC & President of Nanjing Medical University

SHI Yuankai


Vice-Chairman of 2rd PhIRDA Clinical Trial Research Specialty Committee
Professor in Tenure, Chinese Academy of Medical Sciences & Peking Union Medical College
Chairman, Cancer Foundation of China

HUO Yong


Chairman of PhIRDA Clinical Research on Cardiovascular Drugs Specialty Committee
Chief Expert of Cardiology Department, Peking University First Hospital

JI Linong


Chairman of PhIRDA Clinical Research on Diabetes and Metabolic Diseases Specialty Committee
Director of Endocrinology and Metabolism Department, Peking University People's Hospital

LI Jin


Chairman of PhIRDA Clinical Research on Oncology Drugs Specialty Committee
Director of Department of Oncology, Shanghai East Hospital, Tongji University

LI Ning


Member of PhIRDA Clinical Research on Oncology Drugs Specialty Committee
President of Hebei Cancer Hospital, Chinese Academy of Medical Sciences

HU Xin


Chairman of PhIRDA Medicinal Policy Specialty Committee
Chief Pharmacist, Department of Pharmacy, Beijing Hospital

CUI Yimin


Chairman of PhIRDA Clinical Trial Research Specialty Committee
Director of Institute of Clinical Pharmacology, Peking University, PUICP

GAO Zhaobing


Deputy Director,Principal Investigator of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

CHEN Xiaoguang


Member of PhIRDA Drug R&D Specialty Committee
Professor of Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College

WANG Xinghe


Vice-Chairman of PhIRDA Clinical Trial Research Specialty Committee
Chief Physician/Professor, Director of General Office of National Drug & Medical Device Clinical Trial Institute, Director of Phase I Clinical Trial Center

LI Haiyan


Vice-Chairman of PhIRDA Clinical Trial Research Specialty Committee
Director of Drug Clinical Trial Center, Peking University Third Hospital

LI Wenbin


Vice-Chairman & Secretary-General of Clinical Research on Cranial Nerve Drugs Specialty Committee
Chair of Cancer Center, Beijing Tiantan Hospital, Capital Medical University

ZHOU Bing


Professor, Principal Investigator of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

HE Ruyi


Chairman of PhIRDA International Regulatory Science Specialty Committee
CMO of RemeGen, CMO of SDIC
Former Chief Scientist of CDE, CFDA

YANG Dajun


Chairman of PhIRDA Drug R&D Specialty Committee
Chairman of the Board & CEO of Ascentage Pharma

WANG Yinxiang


Vice-Chairman of PhIRDA Drug R&D Specialty Committee
Chairman of the Board & CEO of Jacobio Pharma

FANG Jianmin


Vice-Chairman of PhIRDA Drug R&D Specialty Committee
Co-Founder, CEO & CSO of RemeGen

LIANG Yingyu


Chairman-elected of Pharmaceutical Innovation Investment Specialty Committee
Managing Partner of Qiming Ventures

SUN Zhe


Director of Office for Digitalization on Pharmaceutical Innovation of PhIRDA
Secretary-General of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Managing Partner of Momentum Ventures